Skip to content

BCDA

BioCardia, Inc.

NASDAQ · USHealthcareBiotechnology
$0.84+1.13%

Price as of Jul 20, 2026

BCDA ownership

BioCardia, Inc. ownership & insider activity

Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.

Insider Activity

Sentiment
100/100
Buys (3m)
13
Sells (3m)
0
Net (3m)
$133.9K
Insiders buyingCluster buying
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price -17.5%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 8, 2026Altman Peterdirector, officer: President and CEOBuy5,400$0.96
Jul 7, 2026McClung Davidofficer: Chief Financial OfficerTax23,125$1.24
Jul 7, 2026MOYES JAY MdirectorGrant8,000$1.20
Jul 7, 2026Slosman MarvindirectorGrant8,000$1.20
Jul 7, 2026STERTZER SIMON HdirectorGrant8,000$1.20
Jul 7, 2026Altman Peterdirector, officer: President and CEOGrant57,688$1.20
Jul 7, 2026GILLIS EDWARD Mofficer: Senior Vice President, DevicesTax17,269$1.24
Jul 7, 2026Altman Peterdirector, officer: President and CEOTax54,606$1.24
Jul 7, 2026Allen Jim L.directorGrant8,000$1.20
Jul 7, 2026Blank Andrew ScottdirectorGrant8,000$1.20
Jul 7, 2026GILLIS EDWARD Mofficer: Senior Vice President, DevicesGrant29,442$1.20
Jul 7, 2026McClung Davidofficer: Chief Financial OfficerGrant41,501$1.20
Jul 7, 2026Facteau BilldirectorGrant8,000$1.20
Jul 1, 2026McClung Davidofficer: Chief Financial OfficerGrant60,483$1.20
Jul 1, 2026Altman Peterdirector, officer: President and CEOGrant110,625$1.20
Jul 1, 2026GILLIS EDWARD Mofficer: Senior Vice President, DevicesGrant39,521$1.20
Jun 24, 2026STERTZER SIMON HdirectorBuy70,200$0.92
Jun 24, 2026STERTZER SIMON HdirectorBuy39,000$1.00
Jun 22, 2026Altman Peterdirector, officer: President and CEOBuy800$0.96
Jun 22, 2026Altman Peterdirector, officer: President and CEOBuy1,500$0.85
Jun 9, 2026Altman Peterdirector, officer: President and CEOBuy5,000$0.85
May 21, 2026Altman Peterdirector, officer: President and CEOBuy1,500$0.92
May 21, 2026Altman Peterdirector, officer: President and CEOBuy200$0.95
May 18, 2026Altman Peterdirector, officer: President and CEOBuy5,700$0.92
May 15, 2026Altman Peterdirector, officer: President and CEOBuy5,100$1.02
Apr 29, 2026Altman Peterdirector, officer: President and CEOBuy5,000$1.11
Apr 22, 2026Altman Peterdirector, officer: President and CEOBuy600$1.23
Apr 22, 2026Altman Peterdirector, officer: President and CEOBuy400$1.23
Mar 26, 2026Altman Peterdirector, officer: President and CEOBuy600$1.24
Mar 26, 2026Altman Peterdirector, officer: President and CEOBuy300$1.22

Source: BCDA SEC Form 4 filings, latest Jul 8, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their BCDA positions over the last 6 months (SEC Form 13F).

Increased
5
New positions
6
Reduced
3
Sold out
5
Largest moves
InstitutionActionSharesFiled
CM MANAGEMENT, LLCUnchanged130KMay 8, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position125KMay 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased94KMay 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position66KMay 8, 2026
CITADEL ADVISORS LLCReduced63KMay 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased39KMay 15, 2026
PINGORA PARTNERS LLCIncreased36KMay 15, 2026
BROWN ADVISORY INCUnchanged36KMay 15, 2026
XTX TOPCO LTDIncreased24KMay 15, 2026
VIRTU FINANCIAL LLCNew Position20KMay 14, 2026
COMMONWEALTH EQUITY SERVICES, LLCUnchanged18KApr 27, 2026
TWO SIGMA SECURITIES, LLCNew Position15KMay 15, 2026
RENAISSANCE TECHNOLOGIES LLCNew Position14KMay 14, 2026
MORGAN STANLEYReduced3KMay 15, 2026
TOWER RESEARCH CAPITAL LLC (TRC)Reduced3KMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.